Editorial Staff

  • Executive Editor/VP-Special Projects:
    Jeff Hall
  • Senior Editor
    Brian McCurdy
  • Circulation and Subscriptions
    Bonnie Shannon
  • Art Director:
    Alana Balboni
  • Editorial Correspondence

  • Jeff Hall, Executive Editor/VP-Special Projects, Podiatry Today
  • HMP Communications, 83 General Warren Blvd
    Suite 100, Malvern PA 19355
  • Telephone: (800) 237-7285, ext. 214
    Fax: (610) 560-0501
  • Email: jhall@hmpcommunications.com
  • January 2002 | Volume 15 - Issue 1
    Here is a lateral radiograph of a midfoot Charcot deformity with recurrence after an attempted surgical reconstruction.
    By William Scott Rogers
    14,027 reads | 0 comments | 09/03/08
    When managing patients in the acute phase of Charcot neuroarthropathy, the hallmark of treatment is immobilization and non-weightbearing of the affected foot until the destructive nature of this stage disappears and the coalescence stage begins. In the past decade, researchers have hypothesized that using bisphosphonates in acute Charcot patients can decrease pathological fractures and permanent deformity, which commonly occur in these patients.If this is true, then using bisphosphonates may also lead to less deformity, shorter treatment time, a decreased need for revisional surgery, decreased... continue reading
    By Babak Baravarian, DPM
    84,385 reads | 2 comments | 09/03/08
    Treating forefoot metatarsalgia can be very challenging. In these cases, you’ll often find several differing types of pain and it may be difficult to differentiate the pain according to the patient’s complaints. Be aware the region most often misdiagnosed is forefoot pain surrounding the second metatarsal region. With this in mind, let’s address differing complaints surrounding the second metatarsal region by considering the following case study. ... continue reading